CTRI/2024/02/063380尚未招募2 期
A randomized, comparative, parallel arm, placebo-controlled clinical trial to evaluate the efficacyand safety of Recombinant Vegan Collagen attributing to improving aging-related skin parametersin adults. - NI
Jiangsu JLand Biotech Co., Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male and females aged 30 to 45 years (both inclusive)2.Participants with any one of the following skin conditions along with mild to moderate wrinkles: • Under-eye dark circles, •Hyperpigmentation spots, • Dry dull skin,3.Participants not on any nutritional supplement or not consuming any therapeutic medication for any disorder for the last 45 days;4.Willingness to complete questionnaires, records, and diaries associated with the study and to complete all visits;5. Provided voluntary, written informed consent to participate in the study.
排除标准
- •1. Participants with any chronic illness or any clinical condition;
- •2. Participants who have used a collagen peptide containing
- •supplement in the past 6 months and those who had taken high
- •doses of vitamin C (greater than or equal to 500 mg a day) or any
- •other antioxidant product in the past 1 month;
- •3. Participants who reported substance abuse (alcohol, tobacco,
- •drugs etc.);
- •4. Obese individuals (BMI greater than 30 kg per m2);
- •5. Participation in other clinical trials in last 90 days prior to
- •6. Females who are pregnant and have a positive urine pregnancy
- •test or planning to be pregnant or lactating or not using reliable
- •methods of contraception;
- •7. Any condition that could, in the opinion of the investigator,
- •preclude the participants ability to complete the study or that may
- •confound study outcomes.
研究者
相似试验
已完成
2 期
Clinical study of Anti Hangover Drink NE-AB01 in reducing alcohol induced hangover symptoms in adult male social drinkers.CTRI/2019/05/019412aturedge Beverages Pvt Ltd60
已完成
3 期
Vildagliptin in type 1 diabetes mellitus added to insulitype 1 diabetesGlycamic variabilityHypoglycaemiaMetabolic and Endocrine - DiabetesACTRN12613001056785BakerIDI Heart and Diabetes Institute72
进行中（未招募）
1 期
A randomized, double-blind, parallel-arm, placebo- and comparator-controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 for postoperative pain following abdominal hysterectomy - n.a.Postoperative pain following abdominal hysterectomyMedDRA version: 8.1Level: LLTClassification code 10000075Term: Abdominal hysterectomyEUCTR2006-004998-95-SKGrünenthal GmbH855
进行中（未招募）
不适用
A randomized, double-blind, parallel-arm, placebo- and comparator-controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 for postoperative pain following abdominal hysterectomy - n.a.Postoperative pain following abdominal hysterectomyMedDRA version: 8.1Level: LLTClassification code 10000075Term: Abdominal hysterectomyEUCTR2006-004998-95-HUGrünenthal GmbH855
进行中（未招募）
不适用
A randomized, double-blind, parallel-arm, placebo- and comparator-controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 for postoperative pain following abdominal hysterectomy - n.a.Postoperative pain following abdominal hysterectomyMedDRA version: 8.1Level: LLTClassification code 10000075Term: Abdominal hysterectomyEUCTR2006-004998-95-SIGrünenthal GmbH855